Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Meyers

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Chaos (Woodbury, N.Y.)|December 31, 2020
Cross-recurrence analysis for pattern matching of multidimensional physiological signalsAdam Meyers, Mohammed Buqammaz, Hui Yang
Frontiers in Digital Health|October 18, 2024
Quantifying the impact of surgical teams on each stage of the operating room processAdam Meyers, Mertcan Daysalilar, Arman Dagal, et al.
The Journal of Clinical Psychiatry|January 13, 2006
Wellness intervention for patients with serious and persistent mental illnessVicki Poole Hoffmann, Jonna Ahl, Adam Meyers, et al.
International Journal of Geriatric Psychiatry|October 27, 2005
Olanzapine does not enhance cognition in non-agitated and non-psychotic patients with mild to moderate Alzheimer's dementiaJohn Kennedy, Walter Deberdt, Alan Siegal, et al.
Surgery|July 11, 2025
Automated assessment of laparoscopic pattern cutting skills using computer vision and deep learningFuat Uyguroglu, William Joseph Hoy, Adam Meyers, et al.
The New England Journal of Medicine|September 7, 2022
Trial of Anti-BDCA2 Antibody Litifilimab for Systemic Lupus ErythematosusRichard A Furie, Ronald F van Vollenhoven, Kenneth Kalunian, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|May 22, 2023
Development of a Visit Facilitator Role to Assist Physicians in an Ambulatory Consultative Medical PracticeElizabeth A Gilman, Christopher Aakre, Adam Meyers, et al.
BMJ Open|March 14, 2024
Investigating patient engagement associations between a postdischarge texting programme and patient experience, readmission and revisit rates outcomesCourtenay Bruce, Theresa Pinn-Kirkland, Adam Meyers, et al.
The New England Journal of Medicine|August 8, 2022
Trial of Anti-BDCA2 Antibody Litifilimab for Cutaneous Lupus ErythematosusVictoria P Werth, Richard A Furie, Juanita Romero-Diaz, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Chaos (Woodbury, N.Y.)|December 31, 2020
Cross-recurrence analysis for pattern matching of multidimensional physiological signalsAdam Meyers, Mohammed Buqammaz, Hui Yang
Frontiers in Digital Health|October 18, 2024
Quantifying the impact of surgical teams on each stage of the operating room processAdam Meyers, Mertcan Daysalilar, Arman Dagal, et al.
The Journal of Clinical Psychiatry|January 13, 2006
Wellness intervention for patients with serious and persistent mental illnessVicki Poole Hoffmann, Jonna Ahl, Adam Meyers, et al.
International Journal of Geriatric Psychiatry|October 27, 2005
Olanzapine does not enhance cognition in non-agitated and non-psychotic patients with mild to moderate Alzheimer's dementiaJohn Kennedy, Walter Deberdt, Alan Siegal, et al.
Surgery|July 11, 2025
Automated assessment of laparoscopic pattern cutting skills using computer vision and deep learningFuat Uyguroglu, William Joseph Hoy, Adam Meyers, et al.
The New England Journal of Medicine|September 7, 2022
Trial of Anti-BDCA2 Antibody Litifilimab for Systemic Lupus ErythematosusRichard A Furie, Ronald F van Vollenhoven, Kenneth Kalunian, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|May 22, 2023
Development of a Visit Facilitator Role to Assist Physicians in an Ambulatory Consultative Medical PracticeElizabeth A Gilman, Christopher Aakre, Adam Meyers, et al.
BMJ Open|March 14, 2024
Investigating patient engagement associations between a postdischarge texting programme and patient experience, readmission and revisit rates outcomesCourtenay Bruce, Theresa Pinn-Kirkland, Adam Meyers, et al.
The New England Journal of Medicine|August 8, 2022
Trial of Anti-BDCA2 Antibody Litifilimab for Cutaneous Lupus ErythematosusVictoria P Werth, Richard A Furie, Juanita Romero-Diaz, et al.
Pageof 1